In the year 2010, immunization spending in developing countries increased from US$6 to $15 per infant, on average, and these prices continue to rise. Furthermore, in these countries, many people live on less than $2 per day. This extreme poverty makes paying for vaccines nearly impossible despite their proven cost-effectiveness. As a result, immunization financing is a critical tool for providing access to lifesaving vaccines to those who need them most.
A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines (2012)
An article that applies cost-effectiveness modeling to aid decision-making on rotavirus vaccine introduction in Kenya.
Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review (2012)
An article that documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits.
Featured PATH resources
US Investments in Global Immunization (2013)
A fact sheet that describes investments made by the United States in immunization resources around the world.
Investing in Vaccines for the Developing World (2013)
A fact sheet that details the high cost of developing and distributing vaccines, and outlines the innovative funding solutions designed to address these issues.
Page last updated: June 2013.